The Research Innovation Group (RIG) manages the intellectual property portfolio and industry contracting activities for Saint Louis University.
RIG’s mission is to increase the adoption and dissemination of SLU research discoveries and intellectual properties and to leverage SLU research and innovation assets to benefit the community. Our goal is to become exceptional at technology transfer and industry engagement as well as a partner of choice for research and intellectual property commercialization.
The Research Innovation Group at Saint Louis University strives to be fast, efficient, and helpful when serving community members. Let us know how we can best support you as you pursue truth. Don't hesitate to contact us if you need assistance.
The Research Innovation Group at Saint Louis University is committed to leveraging our research and innovation assets to benefit our community. We strive to generate real impact in tackling social and scientific challenges facing our society through partnerships and programs.
Saint Louis University strives to be a partner of choice for university research and intellectual property commercialization. Please contact us if you would like to discuss specific technologies or other opportunities to collaborate with us.
Search Intellectual Property Portfolio
Use the directory below to browse and search our intellectual property portfolio to identify technologies that may interest you.
ID | Intellectual Property | Type |
---|---|---|
ID | Intellectual Property | Type |
98-002 | Facilitating Research to Develop Treatments for Hemochromatosis | Research Tool |
98-013 | NK3.3 Human Natural Killer Cell Line Derived from Healthy Male | Research Tool |
03-016 | Studying Oncolytic Adenovirus Vectors Using a Syrian Hamster Model | Research Tool |
03-017 | Studying Oncolytic Adenovirus Vectors Using a Cotton Rat Model | Research Tool |
04-011 | Studying Lymphangiogensis-related Immunoresponse to Tumor Cells | Research Tool |
07-006 | Screening for Anti-Adenovirus Agents in Immunosuppressed Individuals | Research Tool |
07-017 | Characterizing an Individual's Risk of Developing Cardiovascular Disease | Diagnostic |
07-023 | Minimizing Risks and Complications Associated with Retinal Detachment Surgery | Medical Device |
10-001 | Improving Weather-Influenced Decisions Using Environmental Predictive Analytics | Industrial Application |
10-010 | Developing an Antiviral Vaccine for Herpes Simplex Virus by Encoding Co-stimulation Molecules | Therapeutic |
10-014 | Improving Robotic Systems for Brain Surgery Using a Self-Opening Distractor | Medical Device |
10-015 | Improving Operating Room Procedures Using a Finger-based Data Input Device | Medical Device |
10-017 | Detecting DNA and RNA Using Biolayer Interferometry with Ultra-High Sensitivity | Diagnostic |
10-018 | Preventing and Treating Influenza Using Peptides to Induce Heterosubtypic Influenza T Cell Responses | Therapeutic |
10-024 | Inexpensively Diagnosing Sickel Cell Disease Under Conditions with Poor Technological Infrastructure | Diagnostic |
10-034 | Detecting and Quantifying Specific Proteins in Biological and Environmental Samples | Diagnostic |
11-003 | Developing Therapies for Various Diseases Such as Fibrosis, Dermal Scarring, Retinal Disease, Cancers, and Viral Infections | Therapeutic |
11-013 | Testing for Inherited Metabolic Diseases | Diagnostic |
11-015 | Novel Approach for Treating Cancer Using Adenovirus E1A Fragments | Drug Delivery |
11-018 | Plasmid Expressing Human Carbonic Anhydrase IV | Research Tool |
11-027 | Treating Cornelia de Lange Syndrome Using Indomethacin-based Drugs | Therapeutic |
11-033 | Preventing Breakage of Electrodes Placed in the Brain to Treat Movement Disorders and Compulsive Disorders | Medical Device |
11-034 | Treating Diseases With Pathologies Promoted by Angiogensis | Therapeutic |
12-001 | Curing Hepatitis B Infections Using a Therapy that Suppresses HBV Replication | Therapeutic |
12-012 | Treating Type I Diabetes Using a Therapy That Targets C-peptide | Research Tool |
12-013 | Preventing Bone Loss by Regulating FOXP3+CD8 T Cells | Therapeutic |
12-014 | Treating Malaria Using Aminohydantoin Compounds | Therapeutic |
12-019 | Measuring HbF in Blood Inexpensively | Diagnostic |
13-014 | Microfluidic Device Systems and Methods for Fabrication | Industrial Application |
13-018 | Inexpensively Predicting Weather Threats With High Spatial and Temporal Resolution | Industrial Application |
13-019 | Treating Facioscapulohumeral Muscular Dystrophy (FSHD) | Therapeutic |
13-026 | Preventing and Treating Herpesvirus Infections from Strains Resistant to Anti-Herpesvirus Drugs | Therapeutic |
14-012 | Treating Chronic Neuropathic Pain | Therapeutic |
14-013 | Delivering Bioactive Components Using a Hydrolytically Degradable Polyethylene Glycol Microsphere | Drug Delivery |
14-016 | Treating Protein C Deficiency | Diagnostic |
14-017 | Diagnosing and Treating Endometriosis-related Infertility | Therapeutic |
14-018 | Novel Therapeutic Strategy for Treating Human Breast Cancer Regulating SALL1 Functions | Therapeutic |
15-004 | Developing Therapies for Various Diseases Such as Fibrosis, Dermal Scarring, Retinal Disease, Cancers, and Viral Infections | Therapeutic |
15-005 | Diagnosing Halogen Gas Exposure and Eosinophil-driven Diseases | Diagnostic |
15-008 | Preventing and Treating Chagas Disease | Research Tool |
15-012 | Producing Biomaterial Platforms for Researching Cell Substrate Relationships | Industrial Application |
15-014 | Treating Cancers, Neurodegenerative Diseases, and Other Rare Conditions Using MUB LBL and LBL-based Peptides | Drug Delivery |
15-016 | Preventing and Treating Herpes Infections | Therapeutic |
15-017 | Preventing and Treating Herpes and Hepatitis Viral Infections | Therapeutic |
15-032 | Promoting Nerve Repair Using Neural Tissue Engineering Method of Transferring Single-Walled Carbon Nanotubes on a Hydrogel | Drug Delivery |
15-036 | Curing Cancer by Unmasking Tumors from the Immune System | Therapeutic |
16-001 | Minimizing the Duration and Toxicity of Treatments for Infections Caused by the Fungal Pathogen Cryptococcus neoformans | Therapeutic |
16-004 | Treating Coagulation Disorders Without Bleeding Side Effects | Therapeutic |
16-006 | Integrating 3-Dimensional Cell Culture Scaffolds in Microfluidic Devices | Industrial Application |
16-011 | Preventing and Treating Infections Caused by Herpesviridae Using Mutant Herpes Simplex Virus | Therapeutic |
16-018 | Producing Nanomaterials Using Mask-free Production Methods | Industrial Application |
16-019 | Providing Immunity Against Divergent Strains of Influenza | Therapeutic |
16-021 | Minimizing the Cost and Time Requirements for Hematopoietic Stem Cell Therapy (HSCT) | Therapeutic |
16-023 | Minimizing Inflammation While Treating Fibrosis | Therapeutic |
17-002 | Novel Antibiotic Candidates Based on Inhibitors of Nucleotidyltransferase Superfamily Enzymes | Therapeutic |
17-003 | Deriving Photoinduced Ring Closure From Dinaphthothiphenes | Industrial Application |
17-004 | Treating Cancers and Infectious Diseases Using NK3.3-Derived Extracellular Vesicles | Therapeutic |
17-007 | Measuring GPER Agonism, Antagonism, and Inverse Agonism Using a Novel High-Throughput Screening Assay | Diagnostic |
17-008 | Maintaining GALNS Enzyme Activity for Extended Periods Using an Injectable Hydrogel Depot | Drug Delivery |
17-010 | Regenerating Tissue Using an Aligned Electrospun Matrix of Decellularized Muscle | Therapeutic |
17-013 | Treating Atherosclerosis by Induction of TcREG | Therapeutic |
17-015 | Treating Short Gut Syndrome and Preventing Necrotizing Enterocolitis Using Fatty Acid Conjugated Epidermal Growth Factor Variants | Therapeutic |
17-017 | Treating Facioscapulohumeral Muscular Dystrophy (FSHD) Using P38 Inhibitors | Therapeutic |
17-024 | Measuring the Efficiency of Efflux Pumps in Bacterial Strains and Permeability Properties of Bacterial Cell Envelopes Using a Molecular Fluorescent Ruler | Diagnostic |
17-026 | Treating Muscle Dysfunction Using ERR Ligands | Therapeutic |
17-029 | Simplifying the Simultaneous Analysis of Multiple Samples Using Mass Spectrometry | Research Tool |
17-033 | Developing More Effective Treatments for Malaria Using Pyrrolidine Compounds | Therapeutic |
17-034 | Assessing Biofilm Infections Using a Novel Bacterial Biofilm Assay | Diagnostic |
17-036 | Treating Malaria Using Novel Clinical Drug Candidates that Exhibit Oral Efficacy with Once Daily Dosing | Therapeutic |
17-037 | Dibenzothiophene Sulfone Cell Dyes | Research Tool |
17-039 | Treating Cancer with Photodynamic Therapy Using Novel Molecules that Induce Apoptosis | Drug Delivery |
17-040 | Improving Cognitive Function in Aging-related Dementia Using Adropun Peptides | Therapeutic |
18-002 | Developing Treatments for Diseases Associated With the CLIC1 Gene | Research Tool |
18-003 | Using Photo-Deoxygenation Induced Apoptosis to Treat Cancer | Therapeutic |
18-010 | Identifying GPER Agonists with Superior Selectivity | Research Tool |
18-020 | Treating Zika Virus Using Selective Estrogen Modulators | Therapeutic |
18-023 | Treating Facioscapulohumeral Muscular Dystrophy (FSHD) Using Pyrrolopyridinone Compounds that Inhibit BET Bromodomains | Therapeutic |
18-024 | Improving the Consistency of Image-guided Head and Neck Radiotherapy Delivery Using an Auto-adaptable Head Rest | Medical Device |
18-026 | Generating Atomic Oxygen Using Visible Light | Drug Delivery |
18-027 | Developing a Functional Cure for Hepatitis B | Therapeutic |
18-028 | Enabling High Precision, Low Cost Deuterium-Based Universal Metabolomic Isotope Labeling | Research Tool |
19-001 | Developing New Types of Molecules for Fluorescent Microscopy | Research Tool |
19-006 | Simplifying the Analysis of Chimerism Data | Research Tool |
19-007 | Detecting Exposure to Specific Pathogens and Agents | Diagnostic |
19-010 | Improving Tumor Immunotherapy by Reprogramming Lipid Metabolism | Therapeutic |
19-011 | Delivering Medicines in a Controlled Manner Over an Extended Period of Time Using Degradable Hydrogels | Drug Delivery |
19-012 | Generating Proteins for High-Throughput Drug Screening Using Customized Plasmids for Expressing Nuclear Receptor Proteins in E. Coli | Therapeutic |
19-014 | Using GCNF Ligands to Increase the Efficacy of Cancer Therapeutics | Therapeutic |
19-015 | Using a Novel Mechanism to Treat MRSA Infections and Tuberculosis | Therapeutic |
19-017 | Improving Telepathology | Medical Device |
19-019 | Treating and Preventing Neuropathic Pain Using Novel Non-Narcotic Analgesics | Therapeutic |
19-020 | Treating Neurological Diseases, Autoimmune Disorders, and Muscular Disorders Using Rev-erb Modulators | Therapeutic |
19-021 | Improving the X-Ray Imaging of the Vasculature of Biological Systems | Diagnostic |
19-027 | Treating Frontotemporal Dementia | Therapeutic |
19-028 | Improving DNA Sequencing | Diagnostics |
19-029 | Treating Traumatic Brain Injuries | Therapeutic |
19-033 | Preventing Rift Valley Fever in Humans | Therapeutic |
20-001 | Creating Exhibitions of Annotated Collections | Industrial Application |
20-003 | Treating Diarrhea in Transplant Patients, AIDS Patients, and Children | Therapeutic |
20-009 | Treating Drug Resistant BRCA-deficient Tumors | Therapeutic |
20-018 | Minimizing the Risks Associated with Supraphysiologic Iron that is Added to Infant Formulas to Offset Poor Iron Absorption | Therapeutic |
20-019 | Evaluating a Variety of Therapeutics for Liver Disease with Robust Internal Control | Research Tool |
20-022 | Diagnosing and Preventing Leukemias That Affect Both Adults and Children | Research Tool |
20-025 | Minimizing Compliance Problems with Type 1 Diabetes Treatment | Therapeutic |
20-026 | Treating Neuropathic Pain with Greater Selectivity | Therapeutic |
21-003 | Minimizing Errors When Treating Diabetes Mellitus with Severe Hyperglycemia or Ketoacidosis | Diagnostic |
21-004 | Facilitating Research to Develop Treatments for HFE-associated Hereditary Hemochromatosis | Research Tool |
21-008 | Treating Neuropathic Pain | Therapeutic |
21-011 | Treating Triple Negative Breast Cancer and Endocrine-Resistant Cancer | Therapeutic |
21-012 | Authenticating Users in a Secure and Non-Intrusive Manner | Industrial Application |
21-014 | Designing Components and Devices with Physical and Electrical Characteristics Not Attainable with Currently Available Materials | Industrial Application |
22-001 | Treating Neurodegenerative Disorders Linked to TDP-43 Pathology | Therapeutic |
22-008 | Maximizing the Yield of Plants and Crops | Industrial Application |
22-009 | Increasing the Yield of Plants and Crops | Industrial Application |
22-018 | Improving the Effectiveness of Drug Screening | Research Tools |
22-020 | Increasing the Efficacy of Cancer Immunotherapy | Therapeutics |
22-026 | Improving the Efficacy of Immunotherapy | Therapeutics |
22-027 | Developing Treatments for Head and Neck Squamous Cell Carcinoma | Research Tools |
22-030 | Mitigating Liver and Gut Injury Associated with Short Gut Syndrome | Medical Devices |
23-001 | Studying Rare Liver Diseases | Research Tools |
23-002 | Preventing Mycobacterium Tuberculosis | Therapeutics |
23-003 | Reducing the Mortality of Invasive Fungal Infections | Therapeutics |